The European Technology Platform on Nanomedicine (ETPN Association), an initiative led by industry and set up together with the European Commission is addressing the application of nanotechnology to achieve breakthroughs in healthcare. Nanomedicine exploits the improved and often novel physical, chemical and biological properties of materials at the nanometer scale. Nanomedicine has the potential to enable early detection and prevention, and to essentially improve diagnosis, treatment and follow-up of diseases. The ETPN Association supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States. As an outcome of last ETPN General Assembly in October 2014 in San Sebastian, the European Technology Platform for Nanomedicine is now ready to tackle new challenges, to gain in visibility and in credibility with a new legal form. The ETPN Association with headquarters in Paris has been officially constituted and is now operational.
